RVL Pharmaceuticals plc Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
RVL Pharmaceuticals plc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2023.
  • RVL Pharmaceuticals plc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $365K, a 58.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $365K -$506K -58.1% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $522K -$597K -53.4% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $512K -$856K -62.6% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 $708K -$943K -57.1% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $871K -$473K -35.2% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.12M -$1.27M -53.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.37M -$585K -30% Dec 31, 2021 10-K 2023-03-20
Q3 2021 $1.65M -$1.58M -48.9% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1.34M -$2.31M -63.3% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $2.39M -$2.09M -46.6% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $1.95M -$1.96M -50.1% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $3.23M -$2.33M -41.8% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $3.66M -$2.72M -42.6% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $4.47M -$1.89M -29.8% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $3.92M -$2.13M -35.2% Dec 31, 2019 8-K 2021-09-08
Q3 2019 $5.56M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $6.38M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $6.36M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $6.04M Jan 1, 2019 10-K 2020-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.